Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
10,863
+51
+0.5% +$5.06K ﹤0.01% 697
2026
Q1
$1.02M Buy
10,812
+2,264
+26% +$226K 0.01% 638
2025
Q4
$844K Buy
+8,548
New +$827K ﹤0.01% 665
2025
Q2
$432K Sell
6,350
-181
-3% -$11.5K ﹤0.01% 842
2025
Q1
$395K Buy
6,531
+864
+15% +$60.3K ﹤0.01% 792
2024
Q4
$391K Buy
5,667
+39
+0.7% +$2.78K ﹤0.01% 768
2024
Q3
$372K Buy
5,628
+1,667
+42% +$106K ﹤0.01% 782
2024
Q2
$240K Buy
3,961
+332
+9% +$18.8K ﹤0.01% 712
2024
Q1
$207K Buy
3,629
+104
+3% +$6.24K ﹤0.01% 728
2023
Q4
$221K Sell
3,525
-7
-0.2% -$396 ﹤0.01% 691
2023
Q3
$204K Sell
3,532
-86,732
-96% -$5.47M ﹤0.01% 666
2023
Q2
$218K Buy
90,264
+76,074
+536% +$5.08M ﹤0.01% 639
2023
Q1
$786K Buy
14,190
+10,688
+305% +$836K 0.01% 336
2022
Q4
$281K Buy
+3,502
New +$268K 0.01% 477
2022
Q3
Sell
-3,600
Closed -$273K 468
2022
Q2
$273K Buy
3,600
+50
+1% +$3.8K 0.01% 500
2022
Q1
$282K Hold
3,550
0.01% 499
2021
Q4
$261K Buy
+3,550
New +$239K 0.01% 483

Other funds holding INCY

EP Wealth Advisors's INCY Position: Q2 2026 in Review

EP Wealth Advisors increased its Incyte (INCY) stake by 0.47% in Q2 2026, buying an estimated $5.06K and bringing the position to 10,863 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #697.

EP Wealth Advisors first reported a position in INCY in Q4 2021 and has held it in 17 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • EP Wealth Advisors held 10,863 shares of Incyte worth $1.23M as of Q2 2026.
  • EP Wealth Advisors bought 51 Incyte shares in Q2 2026, an estimated $5.06K.
  • Incyte made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #697 holding.
  • EP Wealth Advisors first reported a position in Incyte in Q4 2021 and has held it in 17 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.